mk 912 has been researched along with phenoxybenzamine in 1 studies
| Studies (mk 912) | Trials (mk 912) | Recent Studies (post-2010) (mk 912) | Studies (phenoxybenzamine) | Trials (phenoxybenzamine) | Recent Studies (post-2010) (phenoxybenzamine) |
|---|---|---|---|---|---|
| 60 | 3 | 2 | 5,006 | 70 | 95 |
| Protein | Taxonomy | mk 912 (IC50) | phenoxybenzamine (IC50) |
|---|---|---|---|
| Solute carrier family 22 member 2 | Homo sapiens (human) | 4.9 | |
| Solute carrier family 22 member 1 | Homo sapiens (human) | 2.72 | |
| Solute carrier family 22 member 3 | Homo sapiens (human) | 6.13 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eglen, RM; Jasper, JR; Luong, LA; MacLennan, SJ; To, ZP | 1 |
1 other study(ies) available for mk 912 and phenoxybenzamine
| Article | Year |
|---|---|
Characterization of alpha 2-adrenoceptors mediating contraction of dog saphenous vein: identity with the human alpha 2A subtype.
Topics: Animals; Cricetinae; Dogs; Female; Humans; In Vitro Techniques; Male; Norepinephrine; Phenoxybenzamine; Quinolizines; Receptors, Adrenergic, alpha-2; Saphenous Vein; Vasoconstriction; Yohimbine | 1997 |